iSpecimen Inc. (ISPC)
ISPCNASDAQ-CMBiotechnology: Commercial Physical & Biological Resarch
$0.8229
+0.0087 (+1.07%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $1.99m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.7530 to $27.44
- Average volume
- 708.6k
- Previous close
- $0.8142
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $107.0k | $52.0k | $156.0k | $152.0k |
| Gross profit | -$98.0k | -$547.0k | $72.0k | $69.0k |
| Operating income | -$2.83m | -$2.69m | -$2.54m | -$1.36m |
| Net income | -$2.78m | -$5.00m | -$2.27m | -$1.36m |
Last four quarters: revenue $467.0k, margin -2445.4%, free cash flow –
News
7 latest- iSpecimen Inc. Announces $400,000 Private Placement of Series D Convertible Preferred StockFintel · 1 hour ago
- ISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA Decision RTTNews · Sep 8, 2026
- ISpecimen Completes International Cancer Research Order; Stock Down RTTNews · Aug 21, 2026
- ISpecimen Announces Private Placement Worth $2.5 Mln RTTNews · May 11, 2026
- ISpecimen Prices $2.5Mln Private Placement To Support Marketplace Expansion RTTNews · May 11, 2026
- ISpecimen Cuts Shipping Times By 85%, Shares Surge RTTNews · Apr 10, 2026
- ISpecimen Rallies On Biospecimen Marketplace Expansion RTTNews · Mar 13, 2026
The company
iSpecimen (NASDAQ: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations.
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- ispecimen.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.